Akari Therapeutics PLC (AKTX)
1.635
+0.18
(+12.76%)
USD |
NASDAQ |
May 09, 16:00
1.66
+0.02
(+1.53%)
Pre-Market: 20:00
Akari Therapeutics Max Drawdown (5Y): 98.58% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 98.58% |
March 31, 2024 | 97.67% |
February 29, 2024 | 97.66% |
January 31, 2024 | 97.66% |
December 31, 2023 | 97.63% |
November 30, 2023 | 97.54% |
October 31, 2023 | 97.65% |
September 30, 2023 | 97.80% |
August 31, 2023 | 98.50% |
July 31, 2023 | 98.52% |
June 30, 2023 | 98.52% |
May 31, 2023 | 98.52% |
April 30, 2023 | 98.52% |
March 31, 2023 | 98.52% |
February 28, 2023 | 99.12% |
January 31, 2023 | 99.24% |
December 31, 2022 | 99.25% |
November 30, 2022 | 99.25% |
October 31, 2022 | 99.25% |
September 30, 2022 | 99.25% |
August 31, 2022 | 99.25% |
July 31, 2022 | 99.25% |
June 30, 2022 | 99.25% |
May 31, 2022 | 99.25% |
April 30, 2022 | 99.25% |
Date | Value |
---|---|
March 31, 2022 | 99.25% |
February 28, 2022 | 99.25% |
January 31, 2022 | 99.25% |
December 31, 2021 | 99.25% |
November 30, 2021 | 99.25% |
October 31, 2021 | 99.25% |
September 30, 2021 | 99.25% |
August 31, 2021 | 99.25% |
July 31, 2021 | 99.25% |
June 30, 2021 | 99.25% |
May 31, 2021 | 99.25% |
April 30, 2021 | 99.25% |
March 31, 2021 | 99.25% |
February 28, 2021 | 99.25% |
January 31, 2021 | 99.25% |
December 31, 2020 | 99.25% |
November 30, 2020 | 99.25% |
October 31, 2020 | 99.25% |
September 30, 2020 | 99.25% |
August 31, 2020 | 99.25% |
July 31, 2020 | 99.25% |
June 30, 2020 | 99.25% |
May 31, 2020 | 99.25% |
April 30, 2020 | 99.25% |
March 31, 2020 | 99.25% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
97.54%
Minimum
Nov 2023
99.25%
Maximum
May 2019
98.98%
Average
99.25%
Median
May 2019
Max Drawdown (5Y) Benchmarks
DBV Technologies SA | 97.67% |
Cellectis SA | 97.08% |
Adaptimmune Therapeutics PLC | 96.57% |
Biodexa Pharmaceuticals Plc | 100.00% |
NuCana PLC | 98.68% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -66.64 |
Beta (5Y) | 0.9866 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 67.26% |
Historical Sharpe Ratio (5Y) | -0.8274 |
Historical Sortino (5Y) | -1.356 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 36.28% |